Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000597797 | SCV000704466 | pathogenic | not provided | 2016-12-07 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV005091558 | SCV005838088 | pathogenic | Alagille syndrome due to a JAG1 point mutation | 2024-12-04 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ile742Serfs*5) in the JAG1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in JAG1 are known to be pathogenic (PMID: 11180599). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with Alagille syndrome (PMID: 21752016). ClinVar contains an entry for this variant (Variation ID: 499127). For these reasons, this variant has been classified as Pathogenic. |